Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges

According to data provided by World Health Organization, hepatocellular carcinoma (HCC) is the sixth most common cause of deaths due to cancer worldwide. Tremendous progress has been achieved over the last 10 years developing novel agents for HCC treatment, including small-molecule kinase inhibitors...

Descrición completa

Detalles Bibliográficos
Main Authors: Monica A. Kamal, Yasmine M. Mandour, Mostafa K. Abd El-Aziz, Ulrike Stein, Hend M. El Tayebi
Formato: Artigo
Idioma:English
Publicado: MDPI AG 2022-08-01
Series:Molecules
Subjects:
small molecule inhibitors
growth factor receptors inhibitors
tyrosine kinase inhibitors
hepatocellular carcinoma
molecular targets
small molecules as immunomodulators
Acceso en liña:https://www.mdpi.com/1420-3049/27/17/5537

Internet

https://www.mdpi.com/1420-3049/27/17/5537

Títulos similares